Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Taisho scientists isolate and and characterize new antifungal agent

March 5, 1999

Wyeth-Ayerst to market Abelcet in the U.K.

March 5, 1999

Novartis obtains first western approval for new antimalarial drug combination

March 4, 1999

Pfizer claims new, improved compositions of alatrofloxacin

March 4, 1999

New lantibiotic isolated and characterized by U. of Maryland group

March 4, 1999

Cubist Pharmaceuticals initiates pivotal clinical trials for daptomycin

March 3, 1999

Pfizer discloses novel macrolide antibiotics

March 3, 1999

Cubist reports new developments in antibiotic program

Feb. 26, 1999

Bayer claims oxazolidinones active against Gram-positive bacteria and mycobacteria

Feb. 26, 1999

New tradename announced for Magainin's pexiganan

Feb. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...